Company intelligence / Profile preview

Tanomed AB

Sweden

Ownership: Private
Development stage: Other

Overview

Tanomed developed a unique nasal spray designed to relieve and prevent the progression of the common cold by reinforcing the body's own defenses.[1] The company was acquired by Karo Bio in a deal that provided access to this nasal spray technology.

Therapeutic areas: Infectious Diseases
Modalities: Nasal spray
Industry: Biotech

Beyond the preview

Go deeper on Tanomed AB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tanomed AB.

Explore the full profile